Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial

Trial Profile

Prophylactic Use of Immediate Postpartum Sertraline to Prevent Postpartum Depression: A Double Blind Randomized Placebo Controlled Trial

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Sertraline (Primary)
  • Indications Depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Apr 2016 According to ClinicalTrials.gov Status changed from recruiting to discontinued due to Low recruitment, completion of funding cycle.
    • 05 Feb 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov record.
    • 05 Feb 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017, as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top